Lassogen

Developer of new therapeutic modality using lasso peptides to treat difficult diseases such as cancer and autoimmune disorders

placeSan Diego, California, United States calendar_todayFounded 2019 groups12 employees language lassogen.com

Registered entities

Innovation

8 patent families — focus: Chemistry & metallurgy, Physics & computing, Human necessities; filing pace slowing. Cited 79 times.

YearFilings
20191
20202
20214
20224
20234
20242
20253

Investor mix

6 investors on record; lead investors include Playground Global.

Investor typeCountShare
Venture capital467%
Accelerator & incubator117%
Other / undisclosed117%
Coming soon